Company Filing History:
4 out of 10 
2 out of 77 
1 out of 1 Years Active: 2014-2019
Title: Shimon Slavin: Innovator in Neuronal Differentiation
Introduction
Shimon Slavin is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cellular biology, particularly in the area of neuronal differentiation. With a total of six patents to his name, Slavin's work focuses on innovative methods and systems that have the potential to revolutionize treatments for nerve diseases and disorders.
Latest Patents
One of Slavin's latest patents involves methods, systems, and compositions for the neuronal differentiation of multipotent stromal cells. This invention includes techniques to selectively induce neuronal differentiation through the application of specific microRNAs, such as miRNA-124, miRNA-137, and miRNA-9*. The therapeutic administration of these induced cells aims to treat various mammalian injuries and diseases, particularly those affecting the nervous system. Another notable patent focuses on generating a population of cells useful for treating nerve diseases by up-regulating or down-regulating specific miRNAs in mesenchymal stem cells. This method has the potential to create isolated populations of cells with an astrocytic phenotype, which can be utilized in therapeutic applications.
Career Highlights
Throughout his career, Shimon Slavin has worked with notable organizations, including Exostem Biotec Ltd. and Henry Ford Health System. His experience in these companies has allowed him to further develop his innovative ideas and contribute to advancements in medical science.
Collaborations
Slavin has collaborated with several professionals in his field, including Chaya Brodie and Shalva Mardi. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment for research and development.
Conclusion
Shimon Slavin's work in neuronal differentiation and stem cell research showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his significant impact on the field, paving the way for future breakthroughs in the treatment of nerve-related diseases.